VectorY Therapeutics raised €129 million in Series A funding co-led by EQT Life Sciences and Forbion Growth Opportunities Fund.

Biotech Health services

Netherlands

Sweden

United States

Investments

06 November 2023

Share:

VectorY Therapeutics (company)

Netherlands

Biotech Health services

Total investments received (USD): 174.08m

Round value (USD): 136.74m

Round investors: BioGeneration Ventures EQT Partners Forbion Capital Partners Insight Venture Partners MRL Ventures ALS Investment Fund

Company: VectorY Therapeutics

Industry: Biotech Health services

Related deals

Cardior Pharmaceuticals was acquired by Novo Nordisk for 1.025 billion Euro

Biotech Health services Pharma

Germany

Denmark

Secondary 21 March 2024

Tubulis raised €128m in a Series B extension backed by EQT Life Sciences and Nextech Invest

Biotech Health services

Germany

France

Switzerland

Sweden

Belgium

United States

Investments 03 March 2024

DataSnipper to raise a $100 million Series B, led by Index Ventures, at a valuation of $1 billion

AI (big data) Competitive Intelligence Financial Services Software Services

Netherlands

United Kingdom

United States

Investments 29 January 2024

Picnic secures €355 million in a round backed by existing investors The Bill and Melinda Gates Foundation Trust and German supermarket group Edeka.

Ecommerce Food Industry Mobile

Netherlands

Germany

United States

Investments 02 January 2024

Agomab raised $100m in Series C funding led by Fidelity, joined by EQT, Canaan Partners and KKR-controlled Dawn Biopharma

Biotech Health services

Belgium

Sweden

United States

Israel

United Kingdom

Investments 05 October 2023